UPDATE 1-Amgen drug fails to improve survival in multiple myeloma trial
August 13, 2014 at 17:57 PM EDT
(Adds analyst comment, details of Aranesp recall, updates share price)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.